NewsRx

Search our medical news database

Cancer Weekly

Susan Hasty, Publisher

Table of Contents . . . September 21st, 1998

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Weekly | Other Publications

Lung Cancer (Clinical Trial) - Trial of Novel Therapy To Treat Lung Cancer Enrolling Patients

Pediatrics - Childhood Brain Tumors Increase Due to Better Diagnosis and Reporting

Prostate Cancer - Study Finds No Preventive Benefit of Finasteride in High-Risk Men

Prostate Cancer - Study Of Protein Reveals Two Different Cancers

Risk Factors (Bladder Cancer) - Gene Environmental Exposure Interaction Shown to Escalate Smoking-Related Cancer

Testicular Cancer - Unilateral Testicular Cancer Patients Need Lifelong Follow-Up

Pathogenesis (Kaposi's Sarcoma) - "Production of Human (beta) Chemokines in AIDS-Kaposi's Sarcoma Patients."

Combination Therapy - "Primary CNS Lymphoma and HAART."

Pathogenesis (Breast Cancer) - "Activation of Integrin (RGD) or Ceramide (C2) Signalling Pathways in Human Breast Cancer Cell Lines Can Inhibit the Mitogenic Effect of Insulin-Like Growth Factor-I (IGFDA

Therapy (Non-Hodgkin's Lymphoma) - "Idarubicin Contained Regimen in AIDS-Related Non-Hodgkin's Lymphoma Patients (AIDS-NHL Pts). Pilot Study."

Bladder Cancer - "Isolation and Characterization of a Novel Human Bladder Cancer Cell Line: BK10."

Cancer Gene Therapy - "Gene Therapy for Primary and Metastatic Pancreatic Cancer with Intraperitoneal Retroviral Vector Bearing the Wild-Type p53 Gene."

Cancer Immunology - "Human Lung Cancer Cell Lines Express Cell Membrane Complement Inhibitory Proteins and Are Extremely Resistant to Complement-Mediated Lysis; a Comparison with Normal Human Respiratory Epithelium in vitro, and

Cancer Immunotherapy - "Murine Dendritic Cells Pulsed with Whole Tumor Lysates Mediate Potent Antitumor Immune Responses in vitro and in vivo."

Cancer Immunotherapy - "Superantigen-Targeted Therapy: Phase I Escalating Repeat Dose Trial of the Fusion Protein PNU-214565 in Patients With Advanced Gastrointestinal Malignancies."

Immunotoxins - "Humanized M195 Monoclonal Antibody Conjugated to Recombinant Gelonin: An Anti-CD33 Immunotoxin With Antileukemic Activity."

Prostate Cancer - "Cell Cycle-Independent Death of Prostate Adenocarcinoma Is Induced by the trk Tyrosine Kinase Inhibitor CEP-751 (KT6587)."

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook